RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+64.05%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.61B
AUM Growth
+$2.61B
(+13%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
53.33%
Holding
82
New
6
Increased
24
Reduced
27
Closed
10
Top Buys
| 1 |
IMGN
Immunogen Inc
IMGN
|
$183M |
| 2 |
Krystal Biotech
KRYS
|
$76.7M |
| 3 |
Cogent Biosciences
COGT
|
$24.3M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$23.9M |
| 5 |
Zimmer Biomet
ZBH
|
$22M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$102M |
| 2 |
argenx
ARGX
|
$48.6M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
$41.1M |
| 4 |
Sarepta Therapeutics
SRPT
|
$31.9M |
| 5 |
Bristol-Myers Squibb
BMY
|
$31.2M |
Sector Composition
| 1 | Healthcare | 97.02% |
| 2 | Industrials | 2.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
The Oncology Institute
TOI
$302M
| – | – |
-318,082
| Closed | -$216K |
|
|
77
Sarepta Therapeutics
SRPT
$1.98B
| – | – |
-231,595
| Closed | -$31.9M |
|
78
Illumina
ILMN
$15.2B
| – | – |
-33,496
| Closed | -$7.79M |
|
79
Cytosorbents Corp
CTSO
$61.5M
| – | – |
-181,639
| Closed | -$612K |
|
80
Centene
CNC
$14.8B
| – | – |
-277,351
| Closed | -$17.5M |
|
|
81
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-449,442
| Closed | -$31.2M |
|
|
82
argenx
ARGX
$44.2B
| – | – |
-130,540
| Closed | -$48.6M |
|